Evidence mapPaperPMID 39455879Full record

ArticleScientific reports2024

CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics.

K Lee, Y Mai, Z Liu, K Raja, T Jun, M Ma, T Wang, L Ai, E Calay, W Oh and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

K Lee *GeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA. kyeryoung.lee@gmail.com.
Y Mai *GeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
Z Liu *GeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
K RajaGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
T JunGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
M MaGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
T WangGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
L AiGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
E CalayGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
W OhGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
E SchadtGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.
X WangGeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA. xw108@caa.columbia.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of electronic health records (EHRs) holds the potential to enhance clinical trial activities. However, the identification of eligible patients within EHRs presents considerable challenges. We aimed to develop a CriteriaMapper system for phenotyping eligibility criteria, enabling the identification of patients from EHRs with clinical characteristics that match those criteria. We utilized clinical trial eligibility criteria and patient EHRs from the Mount Sinai Database. The CriteriaMapper system was developed to normalize the criteria using national standard terminologies and in-house databases, facilitating computability and queryability to bridge clinical trial criteria and EHRs. The system employed rule-based pattern recognition and manual annotation. Our system normalized 367 out of 640 unique eligibility criteria attributes, covering various medical conditions including non-small cell lung cancer, small cell lung cancer, prostate cancer, breast cancer, multiple myeloma, ulcerative colitis, Crohn's disease, non-alcoholic steatohepatitis, and sickle cell anemia. About 174 criteria were encoded with standard terminologies and 193 were normalized using the in-house reference tables. The agreement between automated and manual normalization was high (Cohen's Kappa = 0.82), and patient matching demonstrated a 0.94 F1 score. Our system has proven effective on EHRs from multiple institutions, showing broad applicability and promising improved clinical trial processes, leading to better patient selection, and enhanced clinical research outcomes.

Indexed as

Clinical Trials as TopicElectronic Health RecordsDatabases, FactualEligibility DeterminationFemaleHumansMalePatient SelectionClinical trialsCohort identificationElectronic healthcare recordsEligibility criteria attribute normalizationEligibility criteria phenotyping

Identifiers

PMID39455879
PMCPMC11511882

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.